Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (3): 278-282.doi: 10.3736/jcim20080312

• Original Experimental Research • Previous Articles     Next Articles

Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG

Yu Hao(), Ping Wang, Jun Wu, Quan-ying Qiu   

  1. Department of Pathogenic Organism and Immunology, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2007-07-25 Online:2008-03-20 Published:2008-03-15
  • Contact: Y Hao

Objective: To observe the effects of ginsenoside (Gs) and berberine (Ber), two kinds of active components of traditional Chinese herbal medicine, on transforming growth factor-beta1 (TGF-β1) and prostaglandin E2 (PGE2) in PG cells.Methods: Co-culture system of human lung carcinoma cell line PG and human T lymphocyte cell line Jurkat was established. PG cells were treated with Gs (100 μg/ml) and Ber (10 μg/ml) for twenty-four hours, and then cocultured with Jurkat cells. After 24-hour coculture, the state of Jurkat cells was observed with inverted microscope. The viable count of Jurkat cells was detected by trypan blue staining after 6- and 24-hour coculture, and the apoptosis of Jurkat cells was evaluated by flow cytometry. PG cells were treated with 100, 50, 25 μg/ml Gs and 10, 5, 2.5 μg/ml Ber respectively, and the content of TGF-β1 and PGE2 in PG cells was detected by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA) method.Results: After coculture with PG cells treated with Gs and Ber, the number of Jurkat cells was less than blank control group, and the apoptosis rates of Jurkat cells in Gs- and Ber-treated groups were higher than blank control group. Gs and Ber could promote the secretion of TGF-β1 in PG cells, but could not change the level of PGE2.Conclusion: Gs and Ber can promote the growth inhibition and apoptosis of Jurkat cells induced by PG cells, which may be related to the up-regulation of Gs and Ber on TGF-β1 secretion in PG cells.

Key words: ginsenosides, berberine, suppressor factors, immunologic, transforming growth factor (31, prostaglandins E

CLC Number: 

  • R734.2

Figure 1

Growth status of Jurkat cells cocultured with PG cells treated with Gs and Ber for 24 h (Inverted microscope, ×100) A: Jurkat cells group (uncocultured control); B: Blank control group (cocultured with untreated PG cells); C: Gs-treated group (cocultured with Gs-treated PG cells); D: Ber-treated group (cocultured with Ber-treated PG cells)."

Table 1

Viable cell count of Jurkat cells after coculture with PG cells ($\bar{x}$±s,105/ml)"

Group n Viable cell count of Jurkat cells
After 6 h coculture After 24 h coculture
Jurkat cells 3 3.0±0.2 5.4±0.3
Blank control 3 2.4±0.2 3.6±0.2
Gs-treated 3 1.4±0.1**△△ 2.2±0.2**△△
Ber-treated 3 2.4±0.1 2.7±0.2**△△

Table 2

Apoptosis rate of Jurkat cells detected by flow cytometry ($\bar{x}$±s, %)"

Group n Early phase (Annexin-V-FITC) Middle-terminal phase ( PI ) Total apoptosis rate
Jurkat cells 3 5.57±1.20 4.67±0.57 10.24±1.49
Blank control 3 11.40±1.94△△ 36.69±2.29△△ 48.10±0.51△△
Gs-treated 3 15.79±0.54*△△ 40.40±1.81△△ 56.19±1.28**△△
Ber-treated 3 12.05±3.28△△ 40.03±3.26△△ 52.08±2.17*△△

Table 3

Content of TGF-β1 and PGE2 in PG cell culture supernatants ($\bar{x}$±s, ng/L)"

Group n TGF-β1 PGE2
Blank control 4 14.9±4.2 28.7±2.3
Gs1 (100 μg/ml)-treated 4 24.9±2.0* 28.9±11.3
Gs2 (50 μg/ml)-treated 4 16.0±3.5 18.2±6.8
Gs3 (25 μg/ml)-treated 4 20.4±2.4 19.1±8.5
Ber1 (10 μg/ml)-treated 4 21.0±1.2 28.9±6.1
Ber2 (5 μg/ml)-treated 4 30.4±4.4* 19.1±7.8
Ber3 (2.5 μg/ml)-treated 4 28.8±4.2* 24.3±1.1

Figure 2

Concentration of TGF-β1 in PG cells"

Figure 3

PG cell number detected by MTT method"

[1] Frumento G, Piazza T, Di Carlo E , et al. Targeting tumor-related immunosuppression for cancer immunotherapy[J]. Endocr Metab Immune Disord Drug Targets, 2006,6(3):233-237
doi: 10.2174/187153006778250019 pmid: 17017974
[2] Fukuchi M, Nakajima M, Miyazaki T , et al. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma[J]. J Surg Oncol, 2006,94(1):51-56
doi: 10.1002/(ISSN)1096-9098
[3] Schneider T, Sailer M, Ansorge S , et al. Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma[J]. J Neurooncol, 2006,79(1):61-65
doi: 10.1007/s11060-005-9116-7
[4] Mouri H, Sakaguchi K, Sawayama T , et al. Suppressive effects of transforming growth factor-beta1 produced by hepatocellular carcinoma cell lines on interferon-gamma production by peripheral blood mononuclear cells[J]. Acta Med Okayama, 2002,56(6):309-315
[5] Ashley DM, Kong FM, Bigner DD , et al. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model[J]. Cancer Res, 1998,59(2):302-309
[6] Harizi H, Norbert G . Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells[J]. Cell Immunol, 2004,228(2):99-109
doi: 10.1016/j.cellimm.2004.04.003
[7] Sherratt PJ , McLellan LI, Hayes JD.Positive and negative regulation of prostaglandin E2 biosynjournal in human colorectal carcinoma cells by cancer chemopreventive agents[J]. Biochem Pharmacol, 2003,66(1):51-61
doi: 10.1016/S0006-2952(03)00206-5
[8] Half E, Tang XM, Gwyn K , et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ[J]. Cancer Res, 2002,62(6):1676-1681
[9] Tatsuka M, Maeda M, Ota T . Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh2[J]. Jpn J Cancer Res, 2001,92(11):1184-1189
doi: 10.1111/cas.2001.92.issue-11
[10] Hao Y, Qiu QY, Wu J , et al. Effect of berberine on lymphocyte-endothelium adhesion and adhesion molecules expression[J]. Zhongguo Mian Yi Xue Za Zhi, 1999,15(11):523-525
郝钰, 邱全瑛, 吴珺 , 等. 小檗碱对淋巴细胞与血管内皮细胞粘附及粘附分子的影响[J]. 中国免疫学杂志, 1999,15(11):523-525
[11] Hao Y, Qiu QY, Fang SP . Flow cytometry analysis of the inhibition of berberine on lymphocyte proliferation[J]. Zhongguo Bing Li Sheng Li Za Zhi, 2000,16(10):1129
郝钰, 邱全瑛, 方素萍 . 小檗碱抑制淋巴细胞增殖的流式细胞分析[J]. 中国病理生理杂志, 2000,16(10):1129
[1] Mohamed S. Othman, Sofian T. Obeidat, Amal H. Al-Bagawi, Mohamed A. Fareid, Alaa Fehaid, Ahmed E. Abdel Moneim. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent#br#
. Journal of Integrative Medicine, 2022, 20(1): 65-72.
[2] Meng-ya Shan, Ying Dai, Xiao-dan Ren, Jing Zheng, Ke-bin Zhang, Bin Chen, Jun Yan, Zi-hui Xu. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. Journal of Integrative Medicine, 2021, 19(6): 545-554.
[3] Hua Zhang, Xiang-yang Yao, Dan-feng Zhang, Qi-le Guo, Jun-jun Yang, Bao-guo Zhu, Dong-xiao Shen, Ke-feng Ruan, Yuan Wang, Jun-liang Peng. Anti-hemorrhoidal activity of Lian-Zhi-San, a traditional Chinese medicine, in an experimental hemorrhoidal model in rats. Journal of Integrative Medicine, 2021, 19(1): 42-49.
[4] Noriko Shinjyo, James Parkinson, Jimmy Bell, Tatsuro Katsuno, Annie Bligh. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Journal of Integrative Medicine, 2020, 18(2): 125-151.
[5] Khanh Nguyen, Jean Sparks, Felix O. Omoruyi. Investigation of the cytotoxicity, antioxidative and immune-modulatory effects of Ligusticum porteri (Osha) root extract on human peripheral blood lymphocytes. Journal of Integrative Medicine, 2016, 14(6): 465-472.
[6] Veena Sharma, Ritu Paliwal, Pracheta Janmeda, Shatruhan Sharma. Renoprotective effects of Moringa oleifera pods in 7,12-dimethylbenz[a]anthracene-exposed mice. Journal of Chinese Integrative Medicine, 2012, 10(10): 1171-1178.
[7] Sunil Kumar, Priyanka Gupta, Shalini Sharma, Dinesh Kumar. A review on immunostimulatory plants. Journal of Chinese Integrative Medicine, 2011, 9(2): 117-128.
[8] Shao-hua SONG, Xiao-yun SHEN, Guo-shan DING, Fang LIU, Zhen-meng WANG, Zhi-ren FU. Effects of astilbin on maturation and immunologic function of mouse bone marrow-derived dendritic cells. Journal of Chinese Integrative Medicine, 2010, 8(2): 145-151.
[9] L Liu, XQ Yue, LN Wang, W Gu, HL Xin, GY Zheng, CQ Ling. Preventive effects of a sachet of Chinese herbs on influenza and its immune regulation. Journal of Chinese Integrative Medicine, 2010, 8(10): 949-954.
[10] WEI Peng, JIAO Lei, QIN Lu-ping, YAN Fei, HAN Ting, ZHANG Qiao-yan. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells. Journal of Chinese Integrative Medicine, 2009, 7(4): 342-348.
[11] Shreeraj H. Shah, Jayvadan K. Patel, Nirav V. Patel. Gastroretentive floating drug delivery systems with potential herbal drugs for Helicobacter pylori eradication: A review. Journal of Chinese Integrative Medicine, 2009, 7(10): 976-982.
[12] Wei Zhang, Liang-duo Jiang, Xiao-mei Zhang, Jian-jun Wu, Yuan Deng, Xiang-feng Lu. Influence of Feixian Formula on serum transforming growth factor-β1 and platelet-derived growth factor in rats with bleomycin-induced pulmonary fibrosis. Journal of Chinese Integrative Medicine, 2008, 6(6): 595-599.
[13] Jia-qing Zhang. Progress of diabetes research in traditional Chinese medicine in recent years. Journal of Chinese Integrative Medicine, 2007, 5(4): 373-377.
[14] Min Li​, Chang-quan Ling​, Xue-qiang Huang​, Zhi-lei Shen. Effects of ginsenosides extracted from ginseng stem and leaves on glucocorticoid receptor in different viscera in heat-damaged rats. Journal of Chinese Integrative Medicine, 2006, 4(2): 156-159.
[15] Dai-wei Cheng​, Yong Zou​, Ning Qian​, Chao-liang Wang​, Ying-biao Tian​, Da-li Wang​, Gui-xiang Zhao​, Zhen-yu Gao​. Effects of compound preparation of Cordyceps sinensis and Tripterygium hypoglaucum on survival time of pigskin after allogeneic transplantation. Journal of Chinese Integrative Medicine, 2006, 4(2): 185-188.
Full text



[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278